scispace - formally typeset
S

Shu Fen Peng

Researcher at National Tsing Hua University

Publications -  6
Citations -  854

Shu Fen Peng is an academic researcher from National Tsing Hua University. The author has contributed to research in topics: Gene delivery & Receptor-mediated endocytosis. The author has an hindex of 6, co-authored 6 publications receiving 797 citations. Previous affiliations of Shu Fen Peng include China Medical University (Taiwan).

Papers
More filters
Journal ArticleDOI

Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.

TL;DR: The in vivo results clearly indicated that the insulin-loaded NPs could effectively reduce the blood glucose level in a diabetic rat model because of their stability in distinct pH environments.
Journal ArticleDOI

The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan

TL;DR: The results obtained in the intracellular trafficking study showed that NPCS NPs entered cells via caveolae and transiently localized to caveosomes before trafficking to the endosomal pathway, suggesting that the prepared NCPS NPs may serve as a carrier for intrACEllular delivery of therapeutic agents.
Journal ArticleDOI

The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery.

TL;DR: Biodegradable nanoparticles, composed of chitosan and poly-gamma-glutamic acid, were prepared by an ionic-gelation method for transdermal DNA delivery using a low-pressure gene gun and revealed that CS/Gamma-PGA/DNA may substitute gold particles as a DNA carrier for transDermal gene delivery.
Journal ArticleDOI

A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs

TL;DR: It was found that the use of a nanoscale drug-entrapment strategy was able to significantly increase the loading efficiency of lipophilic drugs, prevent the drug from aggregation and beneficially reduce its initial burst release; thus, the duration of drug release was extended considerably.
Journal ArticleDOI

The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents.

TL;DR: It is suggested that the developed sirolimus-eluting polymeric stent, made from chitosan-based strips fixed by an epoxy compound, coated with a hydrophobic heparin, can be a potential alternative for treatment of atherosclerosis.